05 August 1995 00:00 [Source: ICB]
HOECHST'S ANIMAL health subsidiary, Hoechst Veterinär, has developed a new antibiotic called Cefquinom which it says will significantly improve treatment of bacterial respiratory infections in cattle. The company said it is the first time the active ingredient, a fourth generation cephalosporin, has been used in veterinary medicine.
* The German pharmaceutical registration agency has given its reasons for rejecting an application by Hoechst's subsidiary Behringwerke for its multiple sclerosis drug based on 15-deoxyspergualin (ECN 1 May). The agency said the drug did not prove to have sufficient therapeutic effect. Behringwerke said it considers data from clinical trials 'positive enough' to warrant registration.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|
Asian Chemical Connections